Streetbeat News

Revenues

MNSB

MainStreet Bancshares (MNSB) reported a significant decrease in Q4 earnings and sales compared to last year. Earnings per share dropped by 35.79% to $0.61 from $0.95, and sales fell by 17.49% to $17.87M, missing the $19.70M estimate.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:05 pm

SSBK

Southern States (NASDAQ:SSBK) reported Q4 adjusted EPS of $0.81, missing the consensus estimate of $0.87 by 6.9%, and a 10% decrease from $0.90 last year. Sales were $23.52M, exceeding the $21.40M estimate by 9.92%, but down 7.71% from $25.49M in the prior year.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:04 pm

ESTA

Establishment Labs has launched its Motiva Implants in China, targeting the plastic and reconstructive surgery market. This expansion into the Chinese market represents a significant step for the company as it taps into one of the largest markets for cosmetic surgery.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:03 pm

XMTR

Xometry (NASDAQ:XMTR) has received mixed ratings from 4 analysts in the past three months, with an average 12-month price target of $38.5, up 46.67% from the previous $26.25. Goldman Sachs analyst Bruno Montanari raised the target to $46, JMP Securities' Nicholas Jones to $42, while RBC Capital's Matthew Hedberg lowered it to $20. Xometry's financials show a 14.83% revenue growth but lag in net margin and ROE compared to industry averages, with a sound debt-to-equity ratio of 0.9.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:01 pm

HD

15 financial analysts have provided mixed evaluations of Home Depot (NYSE:HD) over the past three months, with recent ratings showing no changes in the last 30 days. The average 12-month price target for HD is $345.53, with a high of $400.00 and a low of $299.00, marking a 3.61% increase from the previous average of $333.50. Analysts have adjusted their price targets and ratings, reflecting their latest views on the company's performance and market conditions. Home Depot is the largest home improvement retailer and has expanded through acquisitions. Despite a -2.99% decline in revenue growth, the company maintains a strong net margin of 10.1% and high ROE and ROA, but carries a higher debt-to-equity ratio than the industry average.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

SPWR

SunPower (NASDAQ:SPWR) has received mixed analyst ratings over the past three months, with a shift towards a more bearish outlook in the last 30 days. The average 12-month price target for SPWR has been lowered by 30.23% to $4.5, with a high estimate of $6.00 and a low of $2.50. Analysts from firms including Goldman Sachs, Susquehanna, Wells Fargo, and others have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. SunPower's financials show a revenue decline of -9.59% for the quarter ending September 30, 2023, a net margin of -8.68%, an ROE of -8.31%, and an ROA of -2.47%, with a debt-to-equity ratio of 0.86.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

COMP

Compass (NYSE:COMP) has received mixed analyst ratings over the past three months, with 4 bullish and 2 indifferent ratings. The average 12-month price target is now $3.41, down from $4.38, indicating a 22.15% decrease. Analysts from Needham, Deutsche Bank, Goldman Sachs, and Morgan Stanley have provided various ratings and price target adjustments, reflecting changes in market conditions and company performance. Compass's market capitalization is below industry average, and it faced a revenue decline of -10.46% as of September 30, 2023. However, it has an exceptional net margin of -2.95% and an impressive ROE of -8.55%, but a below-average ROA of -2.93% and a prudent debt-to-equity ratio of 1.18.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

DT

Analysts have recently updated their ratings and price targets for Dynatrace (NYSE:DT), with 6 analysts offering views that range from bullish to bearish. Over the past three months, the sentiment has been predominantly bullish, with 5 bullish and 1 somewhat bullish rating. The average 12-month price target for DT is now $65.00, up from the previous $57.60, indicating a potential increase of 12.85%. Notable analysts from firms like Citigroup, Truist Securities, Jefferies, Scotiabank, and Needham have adjusted their price targets and ratings, reflecting changes in market dynamics and company performance. Dynatrace, a cloud-native company, has shown a revenue growth of 25.91% as of September 30, 2023, but faces challenges with below-average net margin, ROE, and ROA. Its debt-to-equity ratio is below the industry average, suggesting a healthier balance between debt and equity.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

NUKK

Nukkleus Inc. (NASDAQ:NUKK) and its subsidiary, Digital RFQ (DRFQ), have announced a collaboration with Tantel Group to expand in Africa's B2B payments market, valued at over $1.5 trillion. The partnership aims to improve cross-border payment efficiency, reduce costs, and enhance reliability in the region. Nukkleus's CEO emphasized the potential for increased transaction volume for DRFQ as a result of this initiative.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:46 pm

ATHE

Alterity Therapeutics, a biotech company focusing on neurodegenerative diseases, has issued a shareholder letter detailing their 2023 achievements and 2024 goals. They reported hitting all 2023 milestones, particularly in Multiple System Atrophy (MSA) research. Their lead candidate, ATH434, has shown promise in pre-clinical studies and has been granted Orphan Drug Designation by the U.S. FDA and the European Commission. Two Phase 2 trials are underway, with topline results from the ATH434-201 study expected in January 2025 and preliminary data from the ATH434-202 study expected in the first half of 2024. Promising data from a Parkinson's disease primate model was also presented, supporting the potential of ATH434 in treating Parkinson's disease.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:29 pm